Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01941160

Effect of a Lacidofil® STRONG in Healthy Adults Taking Antibiotic Treatment

A Randomized, Placebo Controlled, Parallel Group Study to Evaluate the Effect of a Probiotic Product, Lacidofil® STRONG, in Healthy Adults Taking Antibiotic Treatment

Sponsor: KGK Science Inc.

Conditions Antibiotic Associated Diarrhea

Interventions Lacidofil® STRONG Placebo

Updated 6 times since 2017 Last updated: May 12, 2014 Started: Aug 31, 2013 Primary completion: Apr 30, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Antibiotic Associated Diarrhea, this trial is completed. The trial is conducted by KGK Science Inc. and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Sep 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Sep 2018 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

KGK Science Inc.
Lallemand Health Solutions

Data source: KGK Science Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, Canada